Kazumasa Kase
Kazumasa Kase publishes mostly in Pulmonary and Respiratory Medicine, Epidemiology and Oncology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Inflammatory Myopathies and Dermatomyositis and Cancer Immunotherapy and Biomarkers.
- World rank
- #5,632,689 of 7,710,434 ranked researchers
- Rank in Japan
- #196,324 of 383,136
- Works
- 19
- Citations
- 120
- Citations per work
- 6.3
What does Kazumasa Kase research?
Kazumasa Kase's work is mostly in Medicine (84%), Neuroscience (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1684.2%
- Medicine1684.2%
- Everything else314.0%
- Life Sciences01.8%
- Neuroscience01.8%
- 1Pulmonary and Respiratory Medicine44% of their works
- 2Epidemiology14% of their works
- 3Oncology14% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Rheumatology5% of their works
- 6Endocrine and Autonomic Systems2% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inflammatory Myopathies and Dermatomyositis
- Cancer Immunotherapy and Biomarkers
- Systemic Sclerosis and Related Diseases
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Neuroendocrine Tumor Research Advances
Which keywords describe Kazumasa Kase's research?
The keywords of their largest research topics: Fibrosis, Interstitial Lung Disease, Autoantibodies, Treatment, Idiopathic Pulmonary Fibrosis, TGF-ß, Dermatomyositis and Immune Checkpoint Blockade.
- Pancreatic Neuroendocrine Tumors
- Targeted Therapy
- Pulmonary Alveolar Microlithiasis
- EGFR Mutations
- Systemic Sclerosis
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- TGF-ß
- Treatment
- Interstitial Lung Disease
- Fibrosis
- Autoantibodies
- Idiopathic Pulmonary Fibrosis
- Dermatomyositis
- Inflammatory Myopathies
- Pulmonary Involvement
- CT Screening
- Lung Cancer
- Pulmonary Sclerosing Hemangioma
- Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Fibrosis112 topics
- Interstitial Lung Disease112 topics
- Autoantibodies82 topics
- Treatment82 topics
- Idiopathic Pulmonary Fibrosis71 topic
- TGF-ß71 topic
- Dermatomyositis41 topic
- Immune Checkpoint Blockade41 topic
- Inflammatory Myopathies41 topic
- PD-1 and PD-L141 topic
- Pulmonary Involvement41 topic
- Systemic Sclerosis41 topic
- CT Screening31 topic
- EGFR Mutations31 topic
- Lung Cancer31 topic
- Pulmonary Alveolar Microlithiasis31 topic
- Pulmonary Sclerosing Hemangioma31 topic
- Targeted Therapy31 topic
- Neuroendocrine Tumors21 topic
- Pancreatic Neuroendocrine Tumors21 topic
Where does Kazumasa Kase work?
Kazumasa Kase's main affiliation in the publication record is Kanazawa University, Japan.
How many publications and citations does Kazumasa Kase have?
OpenAlex counts 19 works and 120 citations for Kazumasa Kase, an h-index of 4, ranking #5,632,689 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazumasa Kase. Posts are plain text and can be reported.